BioWa

BioWa’s POTELLIGENT™ service significantly improve the probability of successful mAb development by directly addressing many of the weaknesses that have led to previous failures. More specifically, POTELLIGENT™ efficiently increases the potency and efficacy of your monoclonal antibodies, so that:

Contact Details: 212 Carnegie Center Suite 101 Princeton New Jersey 08540 United States of America Tel: 609-580-7500 Fax: 609-919-1108 Email: info@biowa.com WWW: www.biowa.com/

Loading...

Recent Publications by BioWa:
Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity. Human interleukin-5 is the key cytokine involved in regulating the...	2nd July, 2009	Tokyo Research Laboratories, Kyowa Hakko Kirin, Co., Ltd, Machida-shi,	Hum Antibodies. 2009;18(1-2):17-27. DOI Direct Link

Press Releases on BioWa:
Sorrento Therapeutics Announces the Appointment of Martina Molsbergen as Vice President, Business Development	27th October, 2009	Sorrento Therapeutics, Inc.	SAN DIEGO, Oct. 27 /PRNewswire/ -- Sorrento Therapeutics, Inc. announced today that Martina Molsbergen has joined the Company as Vice President, Business Development. Ms. Molsbergen will focus her
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment	26th October, 2009	Reportlinker	-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
BioWa and NKTT Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development	21st October, 2009	BioWa, Inc.	PRINCETON, N.J. and WALTHAM, Mass., Oct. 21 /PRNewswire/ -- BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with
BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical	5th October, 2009	BioWa, Inc.	PRINCETON, N.J., Oct. 5 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into an agreement with Otsuka Pharmaceutical Co. Ltd. (Otsuka) to provide Otsuka with access to BioWa's
New Report Just Published: World Prostate Cancer Therapeutics Market Report	7th July, 2009	Reportlinker	NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Prostate Cancer Therapeutics Market http://www.reportlinker.com/p0119471/World

BioNews Results for BioWa:
Comprehensive report on world cancer therapies market	News-Medical.Net:  Nov 20 2009 6:46AM Matching: biowa
Successful leukemia treatment with a radiolabeled antibody followed by stem cell transplant	News-Medical.Net:  Nov 6 2009 6:51AM Matching: biowa
Sorrento Therapeutics Announces the Appointment of Martina Molsbergen as Vice President, Business Development	Pharma Live:  Oct 30 2009 6:13PM Matching: biowa
BioWa and NKTT Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Develo	Genetic Engineering News:  Oct 21 2009 11:57AM Matching: biowa
BioWa and NKTT Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Develo	KLFY:  Oct 21 2009 11:37AM Matching: biowa
Promote your company here: BioNewsCast - Press Release Distribution	→View more BioWa news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 237 times since April 2007, the link to the organisation's website has been followed 38 times

Search for more companies in Princeton

Search for more companies in New Jersey

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BioWa